Uses, Dosage & Side Effects: Idhifa Tablet
Idhifa Tablet
| Generic name | enasidenib |
|---|---|
| Drug class | IDH2 inhibitor (isocitrate dehydrogenase-2 inhibitor); listed elsewhere as miscellaneous antineoplastics |
| Forms | Tablets (50 mg), Tablets (100 mg) |
Idhifa is a prescription cancer medicine used to treat adults with a type of blood cancer called acute myeloid leukemia (AML) that has a specific gene change called an IDH2 mutation, and whose disease has come back or has not responded to earlier treatment.
Read the full guideUses, dosage, side effects, precautions, and sources, written from the same verified facts.
General information, not medical advice
Your prescriber and the leaflet in your pack know your situation. This page does not.
- Follow your prescriber and the leaflet
- Don't start, stop, or change a dose on your own
- Doses and warnings differ by country and product
Took too much, or feel seriously unwell? Get urgent medical help now.
Facts checked by a personFull disclaimer
